Literature DB >> 17621371

The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens.

Michael K Maier1, Sebastian Seth, Niklas Czeloth, Quan Qiu, Inga Ravens, Elisabeth Kremmer, Maria Ebel, Werner Müller, Oliver Pabst, Reinhold Förster, Günter Bernhardt.   

Abstract

CD155, originally known as the cellular receptor for poliovirus, is the founding member of a subfamily of immunoglobulin-like adhesion receptors. Apart from its function in establishing adherens junctions between contacting epithelial cells, the engagement of CD155 with two recently identified ligands, CD226 and CD96, mediates immunologically relevant processes such as NK cell-driven killing of tumor cells in humans. Here we report on the generation and immunological analysis of mice constitutively deficient of CD155. Moreover, the expression profile of CD155 on hematopoietic cells has been determined using newly established antibodies. CD155-deficient mice develop normally without displaying an overt phenotype. However, the animals are distinguished by distinct deficits in the development of a regular humoral immune response. Whereas systemic challenges revealed no differences, orally administered antigen evoked less efficient IgG and IgA antibody responses despite of normal IgM titers when compared to wild-type mice. Therefore, CD155 may assist in an efficient humoral immune response generated within the intestinal immune system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621371     DOI: 10.1002/eji.200737072

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.

Authors:  Sebastian Seth; Quan Qiu; Simon Danisch; Michael K Maier; Asolina Braun; Inga Ravens; Niklas Czeloth; Rebecca Hyde; Oliver Dittrich-Breiholz; Reinhold Förster; Günter Bernhardt
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Origin and evolution of the vertebrate leukocyte receptors: the lesson from tunicates.

Authors:  Ivana Zucchetti; Rosaria De Santis; Simona Grusea; Pierre Pontarotti; Louis Du Pasquier
Journal:  Immunogenetics       Date:  2009-04-30       Impact factor: 2.846

3.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

4.  TACTILE becomes tangible: CD96 discloses its inhibitory peculiarities.

Authors:  Günter Bernhardt
Journal:  Nat Immunol       Date:  2014-05       Impact factor: 25.606

Review 5.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

6.  αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities.

Authors:  Anastasia N Tikhonova; François Van Laethem; Ken-ichi Hanada; Jinghua Lu; Leonid A Pobezinsky; Changwan Hong; Terry I Guinter; Susanna K Jeurling; Günter Bernhardt; Jung-Hyun Park; James C Yang; Peter D Sun; Alfred Singer
Journal:  Immunity       Date:  2011-12-29       Impact factor: 31.745

7.  Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice.

Authors:  Tsukasa Nabekura; Kazuko Shibuya; Eri Takenaka; Hirayasu Kai; Kai Shibata; Yumi Yamashita; Kyoichi Harada; Satoko Tahara-Hanaoka; Shin-ichiro Honda; Akira Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

8.  CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.

Authors:  Amelia Roman Aguilera; Viviana P Lutzky; Deepak Mittal; Xian-Yang Li; Kimberley Stannard; Kazuyoshi Takeda; Günter Bernhardt; Michele W L Teng; William C Dougall; Mark J Smyth
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

Review 9.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

10.  A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC.

Authors:  Kent S Boles; William Vermi; Fabio Facchetti; Anja Fuchs; Timothy J Wilson; Thomas G Diacovo; Marina Cella; Marco Colonna
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.